Lexaria Bioscience and Nuka Enterprises’ 1906 Expand Cannabis Product Relationship Cannabis Investing News
Life Science Big News Roundup: Biocure Enters into Exclusive Joint R&D Agreement with Pharos Vaccine Inc.; Bondarenko Acquires 14.48% Beneficial Ownership of BriaCell; Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations Life Science Investing
Immutep Announces Data from Ongoing TACTI-mel Phase I Clinical Trial in Unresectable or Metastatic Melanoma Biotech Investing
Green Growth Brands Completes C$61.2 Million Financing Led By Strategic Investors Cannabis Investing News
Cue Biopharma Announces FDA Acceptance of IND for Lead Immuno-oncology Candidate CUE-101 Biotech Investing
Biocure Enters into Exclusive Joint R&D Agreement with Pharos Vaccine Inc. for Overseas Market of CAR T-Cell Products Biotech Investing
Green Growth Brands Completes 27.3 Million Share Buyback and Cancels 13% of Outstanding Shares Cannabis Investing News
